Matt Dellatorre Analyst Performance

Analyst at The Goldman Sachs Group

Matt Dellatorre is a stock analyst at The Goldman Sachs Group in the healthcare sector, covering 6 publicly traded companies. Over the past year, Matt Dellatorre has issued 8 stock ratings, including buy and hold recommendations. While full access to Matt Dellatorre's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matt Dellatorre's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
11 Last 1 Years
Buy Recommendations
72.73% 8 Buy Ratings
Companies Covered
6 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy72.7%8 ratings
Hold27.3%3 ratings
Sell0.0%0 ratings

Out of 11 total stock ratings issued by Matt Dellatorre at The Goldman Sachs Group, the majority (72.7%) have been Buy recommendations, followed by 27.3% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
50.0% of companies on NASDAQ
3 companies
NYSE
50.0% of companies on NYSE
3 companies

Matt Dellatorre, an analyst at The Goldman Sachs Group, currently covers 6 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
6 companies
100.0%

Matt Dellatorre of The Goldman Sachs Group specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
PHARMACEUTICALS
5 companies
83.3%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
16.7%

Matt Dellatorre's Ratings History at The Goldman Sachs Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
10/16/2026Initiated Coverage$547.18$740.00Buy
Zoetis Inc. stock logo
ZTS
Zoetis
10/16/2026Initiated Coverage$78.68$74.00Neutral
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
10/16/2026Initiated Coverage$23.51$32.00Buy
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
10/16/2026Initiated Coverage$560.36$740.00Buy
Zoetis Inc. stock logo
ZTS
Zoetis
10/16/2026Initiated Coverage$79.31$74.00Neutral
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
2/9/2026Boost Price Target$34.29$45.00Buy
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
12/19/2025Boost Price Target$30.33$35.00Buy
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
12/8/2025Boost Price Target$28.24$31.00Buy
Amneal Pharmaceuticals, Inc. stock logo
AMRX
Amneal Pharmaceuticals
6/6/2025Initiated Coverage$7.17$12.00Buy
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
6/6/2025Initiated Coverage$17.24$24.00Buy
Viatris Inc. stock logo
VTRS
Viatris
6/6/2025Initiated Coverage$8.46$10.00Neutral